|Articles|December 1, 1996

Pharmacoeconomic and Healthcare Outcomes Research: Managing and Treating Hypertension and Cardiovas
Volume 2
Issue 12 Suppl

Felodipine as an Alternative to More Expensive Calcium Antagonists in Mild to Moderate Hypertension

Author(s)Major Frank J. Landry, MD, MPH, Captain J. David Horwhat, MD, David Tomich, PharmD

Download PDF: Felodipine as an Alternative to More Expensive Calcium Antagonists in Mild to Moderate Hypertension

Articles in this issue

about 29 years ago

Article

Introduction

about 29 years ago

Article

Process and Outcome of Outpatient Management of Heart Failure: A Comparison of Cardiologists and Primary Care Providers

about 29 years ago

Article

Gatekeepers and Managed Care: Too Much of a Good Thing?

about 29 years ago

Article

Clinical Outcome of a Mandatory Formulary Switch for Dihydropyridine Calcium Channel Blocker Therapy at a Veteran's Administration Medical Center

about 29 years ago

Article

An Analysis of Costs and Complications of Monophasic and Biphasic Implantable Cardioverter Defibrillators

about 29 years ago

Article

Determinants of Hospital Charges and Costs in Acute Myocardial Infarction: A Report from the Myocardial Infarction Cost Study (MICS) Group

about 29 years ago

Article

Aspirin after Myocardial Infarction: Patient Experience in a Managed Care Setting

about 29 years ago

Article

MANAGED CARE CLINICAL CORNER: Chest Pain

about 29 years ago

Article

Selected Abstracts

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

A Health Economic Evaluation of Digital Digestive Care Management

ByMartha Shepherd, DO, MPH,Pen-Che Ho, MS,David Hines, BA,Jon Harris-Shapiro, BA,Dena Bravata, MD, MS,Christopher M. Whaley, PhD,K. Davina Frick, PhD,Emmanuel F. Drabo, PhD,Ron Z. Goetzel, PhD

January 21st 2026

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

ByShamsi Atefeh, PhD

January 15th 2026

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

ByMohamed M. Ali, MS,Scott Lunos, MS,Zachary Henderson, BSB,Michele Allen, MD, MS,Patricia Adam, MD, MSPH,Genevieve B. Melton, MD, PhD,Rubina Rizvi, MD, PhD

January 12th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Felodipine as an Alternative to More Expensive Calcium Antagonists in Mild to Moderate Hypertension

Articles in this issue

Newsletter

Related Content

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

A Health Economic Evaluation of Digital Digestive Care Management

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

Congress Unveils Massive Funding Bill to Avert Shutdown

Novel CLL Therapies Prompt New Treatment Considerations

Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD

Early Data Show Feasibility of In Vivo CAR T Therapy in Multiple Myeloma